Systems Modeling Identifies Divergent Receptor Tyrosine Kinase Reprogramming to MAPK Pathway Inhibition
Introduction - Targeted cancer therapeutics have demonstrated more limited clinical efficacy than anticipated, due to both intrinsic and acquired drug resistance. Underlying mechanisms have been largely attributed to genetic changes, but a substantial proportion of resistance observations remain une...
Main Authors: | Claas, Allison Mary (Contributor), Atta, Lyla H. (Contributor), Gordonov, Simon (Contributor), Meyer, Aaron Samuel (Contributor), Lauffenburger, Douglas A (Contributor) |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. Department of Biology (Contributor), Massachusetts Institute of Technology. Department of Chemical Engineering (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor) |
Format: | Article |
Language: | English |
Published: |
Springer US,
2018-07-31T15:51:49Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Systems Modeling Identifies Divergent Receptor Tyrosine Kinase Reprogramming to MAPK Pathway Inhibition
by: Meyer, Aaron S., et al.
Published: (2018) -
Systems modeling of quantitative kinetic data identifies receptor tyrosine kinase-specific resistance mechanisms to MAPK pathway inhibition in cancer
by: Claas, Allison
Published: (2017) -
Reprogramming signal transduction through a designer receptor tyrosine kinase
by: Tatphon Kongkrongtong, et al.
Published: (2021-06-01) -
Branched-Chain Amino Acid Metabolic Reprogramming Orchestrates Drug Resistance to EGFR Tyrosine Kinase Inhibitors
by: Yuetong Wang, et al.
Published: (2019-07-01) -
The RON Receptor Tyrosine Kinase Promotes Metastasis by Triggering MBD4-Dependent DNA Methylation Reprogramming
by: Stéphanie Cunha, et al.
Published: (2014-01-01)